Zai Lab Ltd.
(NASDAQ : ZLAB)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -2.11%74.200.0%$2385.66m
NVAXNovavax, Inc. -1.16%171.4999.2%$1382.12m
GILDGilead Sciences, Inc. -0.03%68.981.0%$540.80m
SRNESorrento Therapeutics, Inc. -3.81%13.261.8%$507.36m
AMGNAmgen, Inc. -0.49%240.291.3%$489.78m
REGNRegeneron Pharmaceuticals, Inc. -0.15%623.612.5%$459.89m
BNTXBioNTech SE -3.95%78.090.0%$396.32m
VRTXVertex Pharmaceuticals, Inc. -1.02%270.441.9%$376.97m
BIIBBiogen, Inc. 0.09%276.421.6%$327.90m
ILMNIllumina, Inc. -0.15%400.143.5%$320.15m
VXRTVaxart, Inc. -3.57%9.320.0%$312.61m
IBIOiBio, Inc. -2.16%4.300.2%$179.91m
EBSEmergent BioSolutions, Inc. -1.51%132.426.4%$179.47m
SGENSeattle Genetics, Inc. -0.23%162.216.0%$171.70m
ALXNAlexion Pharmaceuticals, Inc. -0.16%102.592.0%$169.49m

Company Profile

Zai Lab Ltd. is a biopharmaceutical company, which engages in the licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need. Its product pipelines include ZL-2306, ZL-2401, FPA144, ETX2514, and ZL-2301. The company was founded by Samantha Ying Du and Marietta Wu in 2014 and is headquartered in Shanghai, China.